AI assistant
Sending…
RaySearch Laboratories — Major Shareholding Notification 2023
Oct 5, 2023
3101_iss_2023-10-05_60642c46-cb25-4c2b-937c-dec37a0a7262.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer RaySearch Laboratories AB (publ)
Holder
Invesco Ltd.
Instrument
| Instrument | Ordinary SE0000135485 | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 4,065,870 | ||
| Voting rights | 4,065,870 | ||
| Transaction | |||
| Reason for major shareholding notification Sell | |||
| Date | 29/09/2023 | ||
| Limit for number of shares | 5 % | ||
| Limit for number of votes | 5 % | ||
| After the transaction | |||
| Quantity | |||
| Shares | 1,385,379 | ||
| Directly held voting rights | 0 | ||
| Indirectly held voting rights | 1,385,379 | ||
| Percentage | |||
| Directly held shares | 4.04104 % | ||
| Directly held voting rights | 0 % | ||
| Indirectly held voting rights | 1.34271 % | ||
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 1.34271 % | 1,385,379 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
|||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled | |||
| - Cash settled | |||
| Total | 1.34271 % | 1,385,379 | |
| Chain of controlling Voting rights % Voting rights Company |
companies | ||
| 1,385,379 1.34271 | Invesco Advisers, Inc. | ||
| Group total holdings |
|||
| Voting rights | 1,385,379 | ||
| Percentage of voting rights 1.34271 | |||
| Published | |||
| 05/10/2023 11:00 | |||
| Contact | |||
Name Philippa Holmes Phone +01491417447 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from RaySearch Laboratories
AGM Information
2026
May 7
AGM Information
2026
May 7
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 19
Board/Management Information
2026
Apr 19
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Interim / Quarterly Report
2026
Feb 12